EXOZ insider trading
NasdaqCM HealthcareEXOZYMES INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About EXOZYMES INC.
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Company website: www.exozymes.com
EXOZ insider activity at a glance
FilingIQ has scored 12 insider transactions for EXOZ since Jun 13, 2025. The most recent filing in our index is dated Apr 9, 2026.
Across the full history, 1 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on EXOZ insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for EXOZ?
- FilingIQ tracks 12 Form 4 insider transactions for EXOZ (EXOZYMES INC.), covering filings from Jun 13, 2025 onwards. 8 of those were filed in the last 90 days.
- Are EXOZ insiders net buyers or net sellers?
- Across the full Form 4 history for EXOZ, 1 transactions (8%) were open-market purchases and 2 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does EXOZ insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is EXOZ in?
- EXOZYMES INC. (EXOZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $84.87M.
Methodology & sources
Every EXOZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.